Position in AZN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,133,440,495
New position
Shares Held
5,747,087
first reported quarter
Ownership
0.371%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 0.ToString("F0")%
Shared 71.28526155946481.ToString("F0")%
None 28.714738440535182.ToString("F0")%
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $15,736,449,872 across 16 Drug Manufacturers - General names. AZN ranks #6 (7.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
13,779,406 | $3,368,238,000 | |
| 2 | LLY |
ELI LILLY & Co
|
2,984,392 | $2,744,954,225 | |
| 3 | ABBV |
AbbVie Inc.
|
11,068,310 | $2,407,246,738 | |
| 4 | MRK |
Merck & Co., Inc.
|
16,262,708 | $1,956,241,142 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
26,470,718 | $1,605,449,043 | |
| 6 | AZN |
Astrazeneca PLC
This page
|
5,747,087 | $1,133,440,495 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
7,287,230 | $1,015,621,242 | |
| 8 | AMGN |
Amgen Inc
|
2,023,367 | $711,921,677 |
All Filings in AZN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,133,440,495 | 5,747,087 | Shares | Defined | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||